请使用支持JavaScript的浏览器! -Clinical Research Products-Illumina/HumanCytoSNP-12 v2.1 BeadChip Kit (1152 samples)/WG-320-2105/1 Ea
banner
当前位置: 首页 > 产品中心 > Clinical Research Products > Illumina/HumanCytoSNP-12 v2.1 BeadChip Kit (1152 samples)/WG-320-2105/1 Ea

Illumina/HumanCytoSNP-12 v2.1 BeadChip Kit (1152 samples)/WG-320-2105/1 Ea

  • 产品编号: WG-320-2105
  • 美  元  价: $167040.00
  • 会  员  价: 待定
  • 品       牌: Illumina
  • 产       地: 美国
  • 公       司: Illumina, Inc.
  • 产品分类: ref="." class="index">首页 > Illumina/HumanCytoSNP-12 v2.1 BeadChip Kit (1152 samples)/WG-320-2105/1 Ea
  • 公司分类: Clinical Research Products
:1 Ea
Illumina/HumanCytoSNP-12 v2.1 BeadChip Kit (1152 samples)/WG-320-2105/1 Ea
  • Illumina/HumanCytoSNP-12 v2.1 BeadChip Kit (1152 samples)/WG-320-2105/1 Ea
商品介绍

Product Highlights:

The 12-sample HumanCytoSNP-12 BeadChip is a powerful, whole-genome scanning panel designed for efficient, high-throughput analysis of genetic and structural variations that are most relevant to human disease. This scalable, proven solution offers substantially better resolution to detect smaller regions than fluorescence in situ hybridization (FISH) or comparative genomic hybridization (CGH).1

  • Complete panel of genome-wide tag single nucleotide polymorphisms (SNPs) and Markers targeting all regions of known cytogenetic importance, incorporating ~300,000 “best of the best” SNPs with the highest tagging power
  • Average SNP call rates and reproducibility of > 99.9%, and low noise for copy number measurements
  • Detect many types and sizes of structural variation in the human genome that affect phenotypes, including duplications, deletions, amplifications, copy-neutral loss of heterozygosity (LOH), and mosaicism
  • Process up to 12 samples in parallel, increasing sample throughput and decreasing experimental variABIlity
  • Process samples using the single-tube, PCR-free Infinium HD Assay that requires only 200ng DNA per sample
  • Comprehensive data analysis with intuitive BlueFuse Multi Software streamlines copy number assessment and results reporting

The HumanCytoSNP-12 BeadChip is optimized to detect cytogenetic abnormalities most relevant to human disease.1-2 Content includes ~300,000 SNPs targeting regions shown to be important for cytogenetic analysis. The result is dense coverage of ~250 disease regions, including subtelomeric regions, pericentromeric regions, and sex chromosomes, commonly screened in cytogenetics labs. Sufficient SNP coverage is provided to determine dosage sensitivity of > 800 genes.

Specifications:

Assay Time3 days
Hands-On Time1 hour 5 min. for automated 8-beadchip workflow,6 hours 15 min. for manual 8-beadchip workflow
Input Quantity200 ng DNA
MethodGenome-Wide Genotyping Array,Cytogenomic Array
TechnologyMicroarray
Variant ClassSingle Nucleotide Polymorphisms (SNPs),Loss of Heterozygosity (LOH),Chromosomal Abnormalities,Copy Number Variants (CNVs)
System CompatibilityNextSeq 550,iScan
Species CategoryHuman
Cancer TypeHematological,Solid Tumor
品牌介绍

Illumina公司,致力于新一代测序和芯片技术的生产与开发,提供最新的产品与应用资讯。Illumina公司创立于1998年4月,是遗传变异和生物学功能分析领域的优秀的产品、技术和服务供应商。通过帮助客户加快实现生物信息的采集、分析和应用,来改善人类健康。

As a startup, Illumina aspired to transform human health. Our initial products enabled researchers to explore DNA at an entirely new scale, helping them create the first map of gene variations associated with health, disease, and drug response. Every breakthrough opened up a new world, and showed us how much further there is to go

While the rate of progress is accelerating exponentially, we are only beginning to understand the clinical significance of the genome. What causes a cancer cell to mutate? What is the origin of a puzzling disease? Is it possible to prevent the next outbreak? Or safeguard the world’s food supply? These are just a few of the challenges that inspire us to push the boundaries of our imagination

Today we are a global leader in genomics – an industry at the intersection of biology and technology. At the most fundamental level, we enable our customers to read and understand genetic variations. We strive to make our solutions increasingly simple, more accessible, and always reliable. As a result, discoveries that were unimaginable even a few years ago are now becoming routine – and are making their way into patient treatment.

We now have the ability to sequence at an unprecedented scale. Collectively, this will give us a much deeper understanding of genetics than ever before. We will begin to truly unlock the power of the genome. These advances will trigger a fundamental shift in healthcare and beyond. Medicine will continue to become more preventive and more precise. We will be healthier, longer. We have only just begun.

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics


自营商城图标
厂家直采
全球直采模式 正品优价
正品保障图标
正品保障
厂家直发 有线跟踪
解放采购图标
正规清关
CIF100%正规报关,提供发票
及时交付图标
及时交付
限时必达 不达必赔
在线客服
客服电话

4000-520-616

微信交流